The first COVID-19 mRNA manufacturing facility in the Southern Hemisphere is now open in Victoria, Australia, backed by the state and federal Labor governments.
The new mRNA manufacturing facility aims to produce up to 100 million vaccine doses per year for COVID-19, influenza, and Respiratory Syncytial Virus (RSV). However, their production is still subject to regulatory approval.